Neoadjuvant Immunotherapy for Patients With Non–Small Cell Lung Cancer—Is a New Era Coming?
Bo Zhang, Hua Zhong, Baohui Han
Abstract
The Viepoint discusses several points regarding whether there is enough data to accept neoadjuvant immunotherapy as a daily practice for patients with operable non–small cell lung cancer.
Topics & Concepts
MedicineImmunotherapyLung cancerOncologyNeoadjuvant therapyCancerInternal medicineMEDLINEBreast cancerLawPolitical scienceLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations